US · GEHC
GE HealthCare Technologies Inc.
- Sector
- Healthcare · Medical - Healthcare Information Services
- Headquarters
- Chicago, IL 60661
- Website
- gehealthcare.com
Price · as of 2025-12-31
$61.03
Market cap 38.41B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $88.18 | +44.49% |
| Intrinsic Value(DCF) | $41.88 | -31.38% |
| Graham-Dodd Method(GD) | $13.91 | -77.21% |
| Graham Formula(GF) | $58.07 | -4.84% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | $32.98 | $51.52 | |||
| 2022 | $74.60 | $76.93 | $4.33 | $13.49 | $51.27 |
| 2023 | $93.56 | $80.65 | $10.15 | $3.12 | $49.77 |
| 2024 | $86.42 | $79.10 | $13.25 | $9.76 | $38.04 |
| 2025 | $80.16 | $88.18 | $17.16 | $13.91 | $58.07 |
AI valuation
Our deep-learning model estimates GE HealthCare Technologies Inc.'s (GEHC) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $88.18
- Current price
- $61.03
- AI upside
- +44.49%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$41.88
-31.38% upside
Graham-Dodd
$13.91
-77.21% upside
Graham Formula
$58.07
-4.84% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| GEHC | GE HealthCare Technologie… | $61.03 | 38.41B | +44% | -31% | -77% | -5% | 16.99 | 3.53 | 1.77 | 11.12 | 351.11 | -8.63 | 39.99% | 13.39% | 10.10% | 22.88% | 13.96% | 6.15% | 0.96 | 6.14 | 1.18 | 0.93 | 1.45 | 484.00% | 484.00% | -284.00% | 4.12% | 0.22 | 9.78% | 0.17% | 3.00% | 3.44% | 15.24 | 27.95 | 2.04 | 1.89 |
| A | Agilent Technologies, Inc… | $121.38 | 34.41B | -21% | -48% | -87% | -44% | 96.67 | 6.22 | 6.04 | 23.72 | 3059.02 | 23.01 | 52.43% | 21.29% | 18.75% | 6.87% | 16.33% | 3.53% | 0.50 | 13.21 | 1.96 | 1.40 | 0.85 | 316.00% | 673.00% | -1610.00% | 2.75% | 0.66 | 14.01% | 0.67% | 65.00% | 3.31% | 29.43 | 37.78 | 6.26 | 5.50 |
| ALC | Alcon Inc. | $87.18 | 42.49B | -32% | -61% | -65% | -71% | 42.77 | 1.90 | 4.03 | 19.38 | — | 11.11 | 55.24% | 13.08% | 9.42% | 4.50% | 4.55% | 3.17% | 0.24 | — | 2.12 | 1.16 | 1.58 | -341.00% | 494.00% | 2281.00% | 4.12% | 0.74 | 6.84% | 0.40% | 16.90% | 2.12% | 33.49 | 26.36 | 4.38 | 3.24 |
| CAH | Cardinal Health, Inc. | $229.23 | 53.94B | -51% | +121% | — | -82% | 22.84 | -12.89 | 0.16 | 13.30 | 26.27 | -2.40 | 3.67% | 1.02% | 0.70% | -52.35% | -7229.54% | 3.19% | -3.36 | 10.58 | 0.94 | 0.44 | 1.76 | 8696.00% | -187.00% | -4309.00% | 5.16% | 0.06 | -7872.34% | 1.38% | 31.50% | 3.51% | 18.16 | 22.33 | 0.19 | 4.68 |
| HUM | Humana Inc. | $190.54 | 22.92B | -18% | +504% | -67% | -8% | 18.99 | 1.28 | 0.17 | 5.17 | — | 2.83 | 14.54% | 1.12% | 0.92% | 6.98% | 6.79% | 2.49% | 0.70 | 2.30 | 2.00 | 1.42 | 2.81 | -140.00% | 1006.00% | -8432.00% | 1.66% | 0.06 | 2.12% | 1.91% | 36.20% | 5.92% | 10.34 | 40.07 | 0.12 | 4.42 |
| INSM | Insmed Incorporated | $149.33 | 31.85B | -50% | +3,425% | — | — | -24.48 | 42.30 | 51.55 | -26.12 | -162.35 | 61.87 | 79.41% | -194.04% | -210.54% | -249.28% | -969.45% | -59.53% | 1.04 | -14.04 | 3.83 | 3.35 | -0.22 | 1508.00% | 6673.00% | 3709.00% | -3.10% | -1.99 | -797.14% | 0.00% | 0.00% | 1.60% | -26.00 | -31.62 | 50.46 | 8.06 |
| IQV | IQVIA Holdings Inc. | $178.81 | 30.45B | -2% | -53% | — | -39% | 22.01 | 4.61 | 1.84 | 12.70 | 471.04 | -1.99 | 26.28% | 14.02% | 8.34% | 21.65% | 9.92% | 4.79% | 2.49 | 3.14 | 0.75 | 0.67 | 4.10 | 467.00% | 587.00% | -298.00% | 6.85% | 0.32 | 10.54% | 0.00% | 0.00% | 4.15% | 19.23 | 21.45 | 2.70 | 1.83 |
| MTD | Mettler-Toledo Internatio… | $1,366.69 | 27.92B | -28% | -53% | -87% | -63% | 31.42 | -1155.46 | 6.78 | 23.96 | 851.91 | -26.22 | 57.52% | 27.78% | 21.59% | -1154.87% | 44.16% | 25.00% | -99.14 | 16.32 | 1.14 | 0.71 | 1.84 | 369.00% | 398.00% | -183.00% | 3.11% | 0.80 | 40.43% | 0.00% | 0.00% | 2.93% | 26.45 | 34.86 | 7.35 | 10.00 |
| ONC | BeOne Medicines Ltd. | $316.99 | 33.87B | -9% | +1,119% | -83% | -61% | 119.49 | 7.86 | 6.42 | 49.99 | — | 7.98 | 87.49% | 8.37% | 5.37% | 7.46% | 22.87% | 4.07% | 0.25 | 7.68 | 3.41 | 2.96 | -5.60 | -63742.00% | 4023.00% | -24061.00% | 2.75% | 0.62 | 69.99% | 0.00% | 0.00% | 5.56% | 68.95 | 32.74 | 5.77 | 5.43 |
| PHG | Koninklijke Philips N.V. | $32.00 | 30.68B | +25% | -54% | -95% | -76% | 28.63 | 2.34 | 1.44 | 11.71 | — | -29.02 | 45.18% | 7.98% | 5.02% | 7.80% | 6.50% | 3.20% | 0.74 | 4.28 | 1.32 | 0.84 | 2.00 | -22400.00% | -104.00% | -3406.00% | 3.49% | 0.15 | 5.36% | 1.28% | 36.60% | 1.28% | 21.71 | 34.62 | 1.73 | 2.09 |
| RMD | ResMed Inc. | $256.26 | 37.41B | -10% | -40% | -86% | -35% | 28.88 | 6.78 | 7.86 | 20.96 | 77.17 | 16.47 | 59.36% | 32.75% | 27.22% | 25.86% | 25.33% | 18.62% | 0.14 | 133.66 | 3.44 | 2.16 | -0.19 | 3743.00% | 984.00% | 2918.00% | 4.11% | 1.72 | 29.91% | 0.77% | 22.20% | 3.96% | 23.79 | 24.13 | 7.79 | 13.72 |
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
- CEO
- Peter J. Arduini
- Employees
- 53K
- Beta
- 1.23
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($41.88 ÷ $61.03) − 1 = -31.38% (DCF, example).